Cargando…
Going Retro, Going Viral: Experiences and Lessons in Drug Discovery from COVID-19
The severity of the COVID-19 pandemic and the pace of its global spread have motivated researchers to opt for repurposing existing drugs against SARS-CoV-2 rather than discover or develop novel ones. For reasons of speed, throughput, and cost-effectiveness, virtual screening campaigns, relying heavi...
Autores principales: | Wang, Bing, Svetlov, Dmitri, Bartikofsky, Dylan, Wobus, Christiane E., Artsimovitch, Irina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228142/ https://www.ncbi.nlm.nih.gov/pubmed/35744940 http://dx.doi.org/10.3390/molecules27123815 |
Ejemplares similares
-
Papillomaviruses Go Retro
por: Xie, Jian, et al.
Publicado: (2020) -
Go retro and get a GRIP
por: Wong, Kim, et al.
Publicado: (2013) -
NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain
por: Wang, Bing, et al.
Publicado: (2021) -
Going viral: riding the RNA wave to discovery
por: Walter, Nils G.
Publicado: (2015) -
Flipping states: a few key residues decide the winning conformation of the only universally conserved transcription factor
por: Shi, Da, et al.
Publicado: (2017)